MICHAEL W BONNEY Insider Trading $SYRS Syros Pharmaceuticals, Inc.
Get free email notifications about insider trading for MICHAEL W BONNEY.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MICHAEL W BONNEY. MICHAEL W BONNEY is Director in BRISTOL MYERS SQUIBB CO ($BMY) and in CELGENE CORP /DE/ ($CELG) and Director in CELGENE CORP /DE/ ($CELG) and Director in NPS PHARMACEUTICALS INC ($NPSP) and Chief Executive Officer in CUBIST PHARMACEUTICALS INC ($CBST) and President & CEO in CUBIST PHARMACEUTICALS INC ($CBST) and President and CEO in CUBIST PHARMACEUTICALS INC ($CBST) and Director in Sarepta Therapeutics, Inc. ($SRPT) and Director in ALNYLAM PHARMACEUTICALS, INC. ($ALNY) and Director in Syros Pharmaceuticals, Inc. ($SYRS) and Director in Global Blood Therapeutics, Inc. ($GBT) and Director in Tekla World Healthcare Fund ($THW) and Director in Magenta Therapeutics, Inc. ($MGTA) and Director in Kaleido Biosciences, Inc. ($KLDO) and Executive Chair in Kaleido Biosciences, Inc. ($KLDO).
MICHAEL W BONNEY in Syros Pharmaceuticals, Inc.
Trading Symbol: SYRSIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MICHAEL W BONNEY: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 15 2018
$SYRS Market Capitalization: $249.93M
$SYRS Previous Close: $10.92
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of MICHAEL W BONNEY in Syros Pharmaceuticals, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALNY, BMY, CELG, CBST, GBT, KLDO, MGTA, NPSP, SRPT, SYRS, THW
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 15 2018 | SYRS | Syros Pharmaceutic ... | BONNEY MICHAEL W | Director | Option Exercise | A | 12.95 | 13,000 | 168,350 | 13,000 |
Page: 1